PMC:7283670 / 53012-53282 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T191","span":{"begin":243,"end":250},"obj":"Body_part"}],"attributes":[{"id":"A191","pred":"fma_id","subj":"T191","obj":"http://purl.org/sig/ont/fma/fma82749"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T313","span":{"begin":148,"end":166},"obj":"Disease"}],"attributes":[{"id":"A313","pred":"mondo_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/MONDO_0002305"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T527","span":{"begin":216,"end":236},"obj":"http://purl.obolibrary.org/obo/PR_000023540"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43353","span":{"begin":243,"end":250},"obj":"Chemical"}],"attributes":[{"id":"A65677","pred":"chebi_id","subj":"T43353","obj":"http://purl.obolibrary.org/obo/CHEBI_16449"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T29","span":{"begin":120,"end":137},"obj":"http://purl.obolibrary.org/obo/GO_0019079"},{"id":"T30","span":{"begin":120,"end":137},"obj":"http://purl.obolibrary.org/obo/GO_0019058"},{"id":"T31","span":{"begin":225,"end":236},"obj":"http://purl.obolibrary.org/obo/GO_0016791"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}

{"project":"LitCovid-sentences","denotations":[{"id":"T595","span":{"begin":19,"end":60},"obj":"Sentence"},{"id":"T596","span":{"begin":61,"end":195},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T208","span":{"begin":148,"end":166},"obj":"Phenotype"}],"attributes":[{"id":"A208","pred":"hp_id","subj":"T208","obj":"http://purl.obolibrary.org/obo/HP_0100724"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1208","span":{"begin":9,"end":17},"obj":"Species"},{"id":"1220","span":{"begin":61,"end":73},"obj":"Chemical"},{"id":"1415","span":{"begin":148,"end":166},"obj":"Disease"},{"id":"1446","span":{"begin":211,"end":214},"obj":"Gene"},{"id":"1447","span":{"begin":243,"end":267},"obj":"Gene"}],"attributes":[{"id":"A1208","pred":"tao:has_database_id","subj":"1208","obj":"Tax:9606"},{"id":"A1220","pred":"tao:has_database_id","subj":"1220","obj":"MESH:D004176"},{"id":"A1415","pred":"tao:has_database_id","subj":"1415","obj":"MESH:D019851"},{"id":"A1446","pred":"tao:has_database_id","subj":"1446","obj":"Gene:250"},{"id":"A1447","pred":"tao:has_database_id","subj":"1447","obj":"Gene:2875"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"scharged patients: 50% of severe cases and all 4 mild cases.\nDipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery\nAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; A"}